Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

Journal of Pharmaceutical Sciences

Volumn 85, Issue 10, 1996, Pages 1017-1025

  Loftsson, Thorsteinn ^a   Brewster, Marcus E ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Pharmos Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; GLUCOSE DERIVATIVE; OLIGOSACCHARIDE;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG STABILITY; MOLECULAR INTERACTION;

EID: 0029819323     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js950534b     Document Type: Review

References (108)

1. Villiers, A. C. R. Hebd. Seances Acad. Sci. 1891, 112, 536-538.
2. Schardinger, F. Z. Unters. Nahf. Genussm. 1903, 6, 865-880.
3. Schardinger, F. Z. Wien. Klin. Wochenschr. 1903, 16, 486-474.
4. Freundenberg, K.; Cramer, F.; Plieninger, H. Inclusion Compounds of Physiologically Active Organic Compounds. German Patent No. 895, 769, 1953.
5. Frömming, K.-H.; Szeitli, J. Cyclodextrins in Pharmacy; Kluwer Acad. Publ.: Dordrecht, 1994.
6. New Trends in Cyclodextrins and Derivatives; Duchêne, D., Ed.; Editions de Santé: Paris, 1991.
7. Szejtli, J. Cyclodextrin Technology; Kluwer Acad. Publ.: Dordrecht, 1988.
8. Cyclodextrins and their Industrial Uses; Duchêne, D., Ed.; Editions de Santé: Paris, 1987.
9. Loftsson, T.; Brewster, M. E.; Derendorf, H.; Bodor, N. Pharm. Ztg. Wiss. 1991, 4/136, 5-10.
10. Loftsson, T. Drug Stab. 1995, 1, 22-33.
11. Szente, L. In Stability Testing in the EC, Japan and the USA. Scientific and Regulatory Requirements; Grimm, W., Krummen, K., Eds.; Wissenschaftliche Verlagsgesellschaft: Stuttgart, 1993; pp 225-244.
12. van Doorne, H. Eur. J. Pharm. Biopharm. 1993, 39, 133-139.
13. Duchêne, D.; Wouessidjewe, D. Chimicaoggi 1993, Jan/Feb, 17-24.
14. French, D. Adv. Carbohydr. Chem. 1957, 12, 189-260.
15. French, D.; Pulley, A. O.; Effenberger, J. A.; Rougvie, M. A.; Abdullah, M. Arch. Biochem. Biophys. 1965, 111, 153-160.
16. Fujiwara, T.; Tanaka, N.; Kobayashi, S. Chem. Lett. 1990, 739-742.
17. Miyazawa, I.; Ueda, H.; Nagase, H.; Endo, T.; Kobayashi, S.; Nagai, T. Eur. J. Pharm. Sci. 1995, 3, 153-162.
18. Nash, R. A. In Handbook of Pharmaceutical Excipients; Wade, A., Weller, P. J., Eds.; Am. Pharm. Assoc. & Phar. Press: London, 1994; pp 145-148.
19. Higuchi, T.; Connors, K. A. In Advances in Analytical Chemistry and Instrumentation; Reilly, C. N., Ed.; Wiley-Interscience: New York, 1965; Vol. 4, pp 117-212.
20. Hashimoto, H. In New Trends in Cyclodextrins and Derivatives; Duchêne, D., Ed.; Edition de Santé, Paris, 1991; Chapter 3, pp 97-156.
21. Pitha, J.; Milecki, J.; Fales, H.; Pannell, L.; Uekama, K. Int. J. Pharm. 1986, 29, 73-82.
22. Pitha, J.; Rao, C. T.; Lindberg, B.; Seffers, P. Carbohydr. Res. 1990, 200, 429-435.
23. Botsi, A.; Yannakopoulou, K.; Perly, B.; Hajoudis, E. J. Org. Chem. 1995, 60, 4017-4023.
24. Bodor, N.; Huang, M.-J.; Watts, J. D. J. Pharm. Sci. 1995, 84, 330-336.
25. Hirayama, F.; Uekama, K. In Cyclodextrins and their Industrial Uses; Duchêne, D., Ed.; Editions de Santé: Paris, 1987; Chapter 4, pp 131-172.
26. Brewster, M. E.; Estes, K.; Bodor, N. J. Parenter. Sci. Technol. 1989, 43, 262-265.
27. Sigurdardóttir, A. M.; Loftsson, T. Int. J. Pharm. 1995, 126, 73-78.
28. Hussain, M. A.; DiLuccio, R. C.; Maurin, M. B. J. Pharm. Sci. 1993, 82, 77-79.
29. Adachi, H.; Irie, T.; Hirayama, F.; Uekama, K. Chem. Pharm. Bull. 1992, 40, 1586-1591.
30. Lineweaver, H.; Burk, D. J. Am. Chem. Soc. 1934, 56, 658-666.
31. Bettinetti, G. P.; Mura, P.; Liguori, A.; Bramanti, G.; Giordano, F. Farmaco 1989, 44, 195-213.
32. Xiang, T.-X.; Anderson, B. D. Int. J. Pharm. 1990, 59, 45-55.
33. Bekers, O.; Beijnen, J. H.; Otagiri, M.; Bult, A.; Underberg, W. J. M. J. Pharm. Biomed. Anal. 1990, 8, 671-674.
34. Nishijo, J.; Nagai, M. J. Pharm. Sci. 1991, 80, 58-62
35. Liu, F.; Kildsig, D. O.; Mitra, A. K. Pharm. Res. 1992, 9, 1671-1672.
36. Wiese, M.; Cordes, H.-P.; Chi, H.; Seydel, J. K.; Backensfeld, T.; Müller, B.W. J. Pharm. Sci. 1991, 80, 153-156.
37. Boudeville, P.; Burgot, J.-L. J. Pharm. Sci. 1995, 84, 1083-1089.
38. Inoue, Y.; Hakushi, T.; Liu, Y.; Tong, L.-H.; Shen, B.-J.; Jin, D.-S. J. Am. Chem. Soc. 1993, 115, 475-481.
39. Suzuki, M.; Ito, K.; Fushimi, C.; Kondo, T. Chem. Pharm. Bull. 1993, 41, 1444-1447.
40. Uekama, K.; Hirayama, F.; Nasu, S.; Matsuo, N.; Irie, T. Chem. Pharm. Bull. 1978, 26, 3477-3484.
41. Connors, K. A. J. Pharm. Sci. 1995, 84, 843-848.
42. Martin, A. Physical Pharmacy, 4th ed,; Lea & Febiger: Philadelphia, 1993; pp 274-277.
43. Rekharsky, M. V.; Schwarz, F. P.; Tewari, Y. B.; Goldberg, R. N.; Tanaka, M.; Yamashoji, Y. J. Phys. Chem. 1994, 98, 4098-4103.
44. Rekharsky, M. V.; Schwarz, F. P.; Tewari, Y. B.; Goldberg, R. N. J. Phys. Chem. 1994, 98, 10282-10288.
45. Rekharsky, M. V.; Goldberg, R. N.; Schwarz, F. P.; Tewari, Y. B.; Ross, P. D.; Yamashoji, Y.; Inoue, Y. J. Am. Chem. Soc. 1995, 117, 8830-8840.
46. Menard, F. A.; Dedhiya, M. G.; Rhodes, C. T. Pharm. Acta Helv. 1988, 63, 303-308.
47. Menard, F. A.; Dedhiya, M. G.; Rhodes, C. T. Drug Dev. Ind. Pharm. 1990, 16, 91-113.
48. Loftsson, T.; Ólafsdóttir, B. J.; Fridriksdóttir, H.; Jónsdóttir, S. Eur. J. Pharm. Sci. 1993, 1, 95-101.
49. Loftsson, T.; Fridriksdóttir, H.; Sigurdardóttir, A. M.; Ueda, H. Int. J. Pharm. 1994, 110, 169-177.
50. Saenger, W. Angew. Chem., Int. Ed. Engl. 1980, 19, 344-362.
51. Bergeron, R. J. In Inclusion Compounds; Atwood, J. L., Davies, J. E. D., MacNicol, D. D., Eds.; Academic Press: London, 1984; Chapter 12, pp 391-443.
52. Saenger, W. In Inclusion Compounds; Atwood, J. L., Davies, J. E. D., MacNicol, D. D., Eds.; Academic Press, London: 1984; Chapter 8, pp 231-259.
53. Cromwell, W.; Bystrom, K.; Eftink, M. J. Phys. Chem. 1985, 89, 326-332.
54. Cramer, F. Angew. Chem. 1956, 68, 115-120.
55. Tong, W.-Q.; Lach, J. L.; Chin, T.-F.; Guillory, J. K. Pharm. Res. 1991, 8, 951-957.
56. Jones, S. P.; Grant, D. J. W.; Hadgraft, J.; Parr, G. D. Acta Pharm. Technol. 1984, 30, 213-223.
57. Tabushi, I.; Kiyosuke, Y.; Sugiomoto, T.; Yamamura, K. J. Am. Chem. Soc. 1978, 100, 916-919.
58. Orstan, A.; Ross, J. B. A. J. Phys. Chem. 1987, 91, 2735-2745.
59. Pitha, J.; Hoshino, T. Int. J. Pharm. 1992, 80, 243-251.
60. Kraus, C.; Mehnert, W.; Frömming, H.-H. Pharm. Ztg. Wiss. 1991, 136/4, 11-15.
61. Loftsson, T.; Stefánsdóttir, Ó.; Fridriksdóttir, H.; Gudmundsson, Ö. Drug Dev. Ind. Pharm. 1992, 18, 1477-1484.
62. Furuta, T.; Yoshii, H.; Miyamoto, A.; Yasunishi, A.; Hirano, H. Supramol. Chem. 1993, 1, 321-325.
63. Torres-Labndeira, J. J.; Davignon, P.; Pitha, J. J. Pharm. Sci. 1990, 80, 384-386.
64. Loftsson, T.; Fridriksdóttir, H.; Thórisdóttir, S.; Stefánsson, E. Int. J. Pharm. 1994, 104, 181-184.
65. Loftsson, T.; Sigurdardóttir, A. M. Eur. J. Pharm. Sci. 1994, 2, 297-301.
66. Selva, A.; Redenti, E.; Pasini, M.; Ventura, P.; Casetta, B. J. Mass Spectrom. 1995, 30, 219-220.
67. Fenyvesi, É.; Vikmon, M.; Szemán, J.; Szejtli, J.; Ventura, P.; Pasini, M. In The 7th Cyclodextrins Symposium; Osa, T., Ed.; Business Center for Academic Societies Japan: Tokyo, 1994; pp 414-418.
68. Vikmon, M.; Szemán, J.; Szejtli, J.; Pasini, M.; Redenti, E.; Ventura, P. In The 7th Cyclodextrins Symposium; Osa, T., Ed.; Business Center for Academic Societies Japan: Tokyo, 1994; pp 480-483.
69. Sharma, U. S.; Balasubramanian, S. V.; Staubinger, R. M. J. Pharm. Sci. 1995, 84, 1223-1230.
70. Liu, F.; Kildsig, D. O.; Mitra, A. K. Drug Dev. Ind. Pharm. 1992, 18, 1599-1612.
71. Gorecka, B. A.; Sanzgiri, Y. D.; Bindra, D. S.; Stella, V. J. Int. J. Pharm. 1995, 125, 55-61.
72. Cserháti, T. Int. J. Pharm. 1995, 124, 205-211.
73. Helm, H.; Müller, B. W.; Waaler, T. Eur. J. Pharm. Sci. 1995, 3, 195-201.
74. Backensfeld, T.; Müller, B. W.; Kolter, K. Int. J. Pharm. 1991, 74, 85-93.
75. Loftsson, T.; Gudmundsdóttir, T. K.; Fridriksdóttir, H. Drug Dev. Ind. Pharm. 1996, 22, 403-407.
76. Haldon, T.; Cwiertina, B. Pharmazie 1994, 49, 497-500.
77. Utsuki, T.; Hirayama, F.; Uekama, K. J. Chem. Soc., Perkin Trans. 2 1993, 109-114.
78. Hirayama, F.; Utsuki, T.; Uekama, K.; Yamasaki, M.; Harata, K. J. Pharm. Sci. 1992, 81, 817-822.
79. Utsuki, T.; Imamura, K.; Hirayama, F.; Uekama, K. Eur. J. Pharm. Sci. 1993, 1, 81-87.
80. Jarho, P.; Urtti, A.; Järvinen, T. Pharm. Res. 1995, 12, 1371-1375.
81. Asker, A.; Habib, M. J. Parenter. Sci. Technol. 1988, 42, 153-156.
82. Beijnen, J.; van der Houwen, O.; Underberg, W. J. M. Int. J. Pharm. 1986, 32, 123-131.
83. Janssen, M.; Crommelin, D.; Storm, G.; Hulshoff, A. Int. J. Pharm. 1985, 23, 1-11.
84. Beijnen, J.; Wiese, G.; Underberg, W. J. M. Pharm. Weekbl. Sci. 1985, 7, 109-116.
85. Wasserman, K.; Bundgaard, H. Int. J. Pharm. 1983, 14, 73-78.
86. Husain, N.; Ndou, T. T.; de la Peña, A. M.; Warner, I. M. Appl. Spectrosc. 1992, 46, 652-658.
87. Suenaga, A.; Bekers, O.; Beijnen, J. H.; Underberg, W. J. M.; Tanimoto, T.; Koizumi, K.; Otagiri, M. Int. J. Pharm. 1992, 82, 29-37.
88. Bekers, O.; Beijnen, J.; Bramel, E.; Otagiri, M.; Underberg, W. J. M. Pharm. Weekbl. Sci. 1988, 10, 207-212.
89. Brewster, M. E.; Loftsson, T.; Estes, K. S.; Lin, J. L.; Fridriksdóttir, H.; Bodor, N. Int. J. Pharm. 1992, 79, 289-299.
90. Jones, R. A. Y. Physical and Mechanistic Organic Chemistry; Cambridge Univ. Press: London, 1979; pp 227-235.
91. Järvinen, K.; Järvinen, T.; Thompson, D. O.; Stella, V. J. Curr. Eye Res. 1994, 13, 897-905.
92. Adachi, H.; Irie, T.; Hirayama, F.; Uekama, K. Chem. Pharm. Bull. 1992, 40, 1586-1591.
93. Kikuchi, M.; Hirayama, F.; Uekama, K. Int. J. Pharm. 1987, 38, 191-198.
94. Yamamoto, M.; Hirayama, F.; Uekama, K. Chem. Pharm. Bull. 1992, 40, 747-751.
95. Uekama, K.; Ikegami, K., Wang, Z.; Horiuchi, Y.; Hirayama, F. J. Pharm. Pharmacol. 1992, 44, 73-78.
96. Hirayama, F.; Wang, Z.; Uekama, K. Pharm. Res. 1994, 11, 1766-1770.
97. Brewster, M. E.; Simpkins, J. W.; Hora, M. S.; Stern, W. C.; Bodor, N. J. Parenter. Sci. Technol., 1989, 43, 231-240.
98. Brewster, M. E.; Simkins, J.; Hora, M.; Bodor, N. Pharm. Res. 1991, 8, 792-795.
99. Manning, M. C.; Patel, K.; Borchardt, R. T. Pharm. Res. 1989, 6, 903-918.
100. Hagenlocher, M.; Pearlman, R. Pharm. Res. 1989, 6, S30.
101. Fukunaga, K.; Hijikata, S.; Ishimura, K.; Sonoda, R.; Irie, T.; Uekama, K. J. Pharm. Pharmacol. 1994, 46, 168-171.
102. Tokihiro, K.; Irie, T.; Uekama, K.; Pitha, J. Pharm. Sci. 1995, 1, 49-53.
103. Brown, N. D.; Butler, D. L.; Chiang, P. K. J. Pharm. Pharmacol. 1993, 45, 666-667.
104. Fujiwara, H.; Kawashima, S.; Yamada, Y. Chem. Pharm. Bull. 1985, 33, 5458-5463.
105. Connors, K. A.; Amidon, K. L.; Stella, V. J. Chemical Stability of Pharmaceuticals; Wiley: New York, 1986; pp 250-256, 309-314.
106. Loftsson, T.; Jóhannesson, H. R. Pharmazie 1994, 49, 292-293.
107. Choudhury, S.; Mitra, A. K. Pharm Res. 1993, 10, 156-159.
108. Beyrich, T.; Jira, T.; Beyer, C. Chirality 1995, 7, 560-564.